Key regions: United Kingdom, China, Europe, India, France
The Other Vaccines market in Australia & Oceania has been steadily developing in recent years.
Customer preferences: Customers in Australia & Oceania are becoming increasingly aware of the importance of vaccination and are seeking out vaccines for a variety of illnesses. Additionally, the region's aging population has led to an increase in demand for vaccines that protect against diseases such as shingles and pneumonia.
Trends in the market: One trend in the Other Vaccines market in Australia & Oceania is the increasing popularity of travel vaccines. As international travel becomes more accessible and affordable, more people are traveling to exotic destinations and require vaccines to protect against diseases such as yellow fever and typhoid. Another trend is the growing demand for vaccines that protect against sexually transmitted infections, such as human papillomavirus (HPV).
Local special circumstances: Australia & Oceania has a unique geography and climate that presents specific health risks. For example, the region is home to a variety of venomous creatures, such as snakes and spiders, which can pose a threat to human health. As a result, there is a demand for vaccines that protect against these venomous creatures. Additionally, the region's high UV index and outdoor lifestyle has led to a demand for vaccines that protect against skin cancer.
Underlying macroeconomic factors: The Other Vaccines market in Australia & Oceania is driven by a number of macroeconomic factors. One factor is government investment in healthcare, which has led to increased access to vaccines for the general population. Another factor is the region's high standard of living, which has led to a greater demand for preventative healthcare measures such as vaccination. Additionally, the region's strong economy has led to increased spending on healthcare, including vaccines.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
